APPLICATION DISCLOSURES CONTAINING NUCLEOTIDE AND/OR AMINO ACID SEQUENCES
- Section 1.821 - Nucleotide and/or amino acid sequence disclosures in patent applications
- Section 1.822 - Symbols and format to be used for nucleotide and/or amino acid sequence data
- Section 1.823 - Requirements for content of a "Sequence Listing" part of the specification
- Section 1.824 - Form and format for a nucleotide and/or amino acid sequence submission as an ASCII plain text file
- Section 1.825 - Amendment to add or replace a "Sequence Listing" and CRF copy thereof
- Section 1.831 - Requirements for patent applications filed on or after July 1, 2022, having nucleotide and/or amino acid sequence disclosures
- Section 1.832 - Representation of nucleotide and/or amino acid sequence data in the "Sequence Listing XML" part of a patent application filed on or after July 1, 2022
- Section 1.833 - Requirements for a "Sequence Listing XML" for nucleotide and/or amino acid sequences as part of a patent application filed on or after July 1, 2022
- Section 1.834 - Form and format for nucleotide and/or amino acid sequence submissions as the "Sequence Listing XML" in patent applications filed on or after July 1, 2022
- Section 1.835 - Amendment to add or replace a "Sequence Listing XML" in patent applications filed on or after July 1, 2022
- Section 1.839 - [Effective 7/1/2024] Incorporation by reference
- Section 1.839 - [Effective until 7/1/2024] Incorporation by reference